唐杰

医生简介

唐杰，男，广州市番禺中心医院肿瘤科住院医师。本科就读于南华大学医学院，学习临床医学专业。于2013年考入中山大学肿瘤防治中心攻读硕士学位，期间跟随谢方云教授学习肿瘤放射治疗学，2016年硕士毕业后开始在番禺区中心医院肿瘤科工作。在鼻咽癌、喉癌、乳腺癌、宫颈癌、食管癌等多种肿瘤的治疗领域有着丰富的临床经验。在攻读硕士期间，参与了多项科学研究，以共同第一作者和共同作者的身份在多种国际医学期刊上发表SCI收录的论文8篇。科研项目、获奖成果、专利、发表论著等情况：1. Zhang LN, Tang J, Lan XW, OuYangPY, Xie FY . Pretreatment anemia and survival in nasopharyngeal carcinoma. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2015.doi:10.1007/s13277-015-4042-6.2. Su Z, Mao YP, Tang J, Lan XW, OuYang PY, Xie FY. Long-term outcomes of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma treated with IMRT: a retrospective study. Tumour biology : the journal of the International Society for Oncodevelopmental Biologyand Medicine. 2015. doi:10.1007/s13277-015-4266-5.3. Su Z, Mao YP, OuYang PY, Tang J, Lan XW, Xie FY. Leucopenia and treatment efficacy in advanced nasopharyngeal carcinoma. BMC cancer. 2015;15:429. doi:10.1186/s12885-015-1442-3.4. OuYang PY, Zhang LN, Lan XW, Xie C, Zhang WW, Wang QX et al.The significant survival advantage of female sex in nasopharyngeal carcinoma: a propensity-matched analysis. British journal of cancer. 2015;112(9):1554-61. doi:10.1038/bjc.2015.70.5. OuYang PY, Su Z, Tang J, Lan XW, Mao YP, Deng W et al. Diabetes, prediabetes and the survival of nasopharyngeal carcinoma: a study of 5,860 patients. PloS one. 2014;9(10):e111073. doi:10.1371/journal.pone.0111073.6. Su Z, Mao YP, OuYang PY, Tang J, Xie FY. Initial Hyperleukocytosis and Neutrophilia in Nasopharyngeal Carcinoma: Incidence and Prognostic Impact. PloS one. 2015;10(9):e0136752. doi:10.1371/journal.pone.0136752.7. Zhang LN, Gao YH, Lan XW, Tang J, OuYang PY, Xie FY. Effect of taxanes-based induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: A large scale propensity-matched study. Oral oncology. 2015. doi:10.1016/j.oraloncology.2015.07.004.8. Zhang LN, Gao YH, Lan XW, Tang J, Su Z, Ma J et al. Propensity score matching analysis of cisplatin-based concurrent chemotherapy in low risk nasopharyngeal carcinoma in the intensity-modulated radiotherapy era. Oncotarget. 2015. doi:10.18632/oncotarget.5806.